ClearPoint Neuro (CLPT) Liabilities and Shareholders Equity (2011 - 2026)

ClearPoint Neuro has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $93.4 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 210.66% year-over-year to $93.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $314.4 million (up 94.04% YoY) and the FY2025 annual result came in at $97.7 million, up 149.42% from the prior year.
• Liabilities and Shareholders Equity declined to $93.4 million in Q1 2026 per CLPT's latest filing, from $97.7 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $97.7 million in Q4 2025 and troughed at $30.1 million in Q1 2025.
• A 5-year average of $55.9 million and a median of $53.6 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity plunged 43.94% in 2025, then jumped 210.66% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $55.5 million in 2022, then dropped by 23.12% to $42.7 million in 2023, then decreased by 8.14% to $39.2 million in 2024, then jumped by 149.42% to $97.7 million in 2025, then fell by 4.43% to $93.4 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $93.4 million, $97.7 million, and $60.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.